Growth Metrics

Apellis Pharmaceuticals (APLS) Current Deferred Revenue (2024)

Historic Current Deferred Revenue for Apellis Pharmaceuticals (APLS) over the last 1 years, with Q3 2024 value amounting to $1.9 million.